Number and rate* of newly reported cases† of chronic hepatitis C, by demographic characteristics — United States, 2022
Characteristics | No. | Rate* |
---|---|---|
Total§ | 93,805 | 40.2 |
Age (years) | ||
0–19 | 885 | 1.6 |
20–29 | 10,833 | 35.0 |
30–39 | 25,192 | 80.2 |
40–49 | 18,414 | 64.9 |
50–59 | 15,805 | 53.5 |
≥60 | 22,338 | 38.9 |
Sex | ||
Male | 60,646 | 52.5 |
Female | 32,553 | 27.6 |
Race/ethnicity | ||
American Indian/Alaska Native, non-Hispanic | 1,834 | 104.8 |
Asian/Pacific Islander, non-Hispanic | 740 | 6.5 |
Black, non-Hispanic | 9,938 | 30.6 |
White, non-Hispanic | 47,269 | 31.3 |
Hispanic | 4,112 | 13.1 |
Other | 4,704 | n/a |
Urbanicity ¶ | ||
Urban | 71,904 | 37.1 |
Rural | 21,016 | 58.5 |
HHS region** | ||
Region 1: Boston | 4,009 | 26.5 |
Region 2: New York | 6,643 | 23.0 |
Region 3: Philadelphia | 13,850 | 44.3 |
Region 4: Atlanta | 27,664 | 51.7 |
Region 5: Chicago | 12,585 | 27.4 |
Region 6: Dallas | 12,308 | 89.4 |
Region 7: Kansas City | 5,713 | 40.0 |
Region 8: Denver | 4,317 | 34.2 |
Region 9: San Francisco | 1,846 | 58.1 |
Region 10: Seattle | 4,870 | 33.1 |
Source: CDC, National Notifiable Diseases Surveillance System.
* Rates per 100,000 population.
† Reported confirmed cases. For the case definition, see Chronic Hepatitis C.
§ Numbers reported in each category may not add up to the total number of reported cases in a year due to cases with missing data.
¶ Urbanicity was categorized according to the 2013 National Center for Health Statistics (NCHS) urban-rural classification scheme for counties and county-equivalent entities. Large central metro, large fringe metro, medium metro, and small metro counties were grouped as urban. Micropolitan and noncore counties were grouped as rural.
** US Department of Health and Human Services regions were categorized according to the grouping of states and US territories assigned under each of the 10 Health and Human Services regional offices. For the purposes of this report, regions with US territories (Region 2 and Region 9) contain data from states only.
n/a: Not applicable. Rate cannot be calculated due to lack of corresponding denominator.
During 2022, the rates of newly reported chronic hepatitis C were highest among persons aged 30–39 years, males, non-Hispanic American Indian/Alaska Native persons, those living in rural areas, and persons in US Department of Health and Human Services Region 6 (Arkansas, Louisiana, New Mexico, Oklahoma, and Texas). Among all newly reported chronic hepatitis C cases during 2022, 27% occurred among persons aged 30–39 years, 65% occurred among males, and 76% occurred in urban areas. Race and ethnicity information was only available for 68,597 (73%) cases of newly reported chronic hepatitis C; after excluding cases with missing race and ethnicity information, 69% of cases occurred among non-Hispanic White persons. Variations of disease rates by race or ethnicity may reflect systemic cultural, behavioral, environmental, and social factors, including structural racism.
- Figure 3.1. Number of reported cases and estimated infections of acute hepatitis C — United States, 2015–2022
- Figure 3.2. Rates of reported cases of acute hepatitis C, by state or jurisdiction — United States, 2021–2022
- Figure 3.3. Rates of reported cases of acute hepatitis C, by state or jurisdiction — United States, 2022
- Figure 3.4. Rates of reported cases of acute hepatitis C, by age group — United States, 2007–2022
- Figure 3.5. Rates of reported cases of acute hepatitis C, by sex — United States, 2007–2022
- Figure 3.6. Rates of reported cases of acute hepatitis C, by race/ethnicity — United States, 2007–2022
- Figure 3.7. Availability of information on risk behaviors or exposures associated with reported cases of acute hepatitis C — United States, 2022
- Figure 3.8. Number of newly reported chronic hepatitis C cases by sex and age — United States, 2022
- Figure 3.9. Rates of deaths with hepatitis C listed as a cause of death among residents, by state or jurisdiction — United States, 2022
- Table 3.1. Numbers and rates of reported cases of acute hepatitis C, by state or jurisdiction — United States, 2018–2022
- Table 3.2. Numbers and rates of reported cases of acute hepatitis C, by demographic characteristics — United States, 2018–2022
- Table 3.3. Reported risk behaviors or exposures among reported cases of acute hepatitis C — United States, 2022
- Table 3.4. Number of newly reported cases of perinatal hepatitis C, by state or jurisdiction — United States, 2022
- Table 3.5. Number and rate of newly reported cases of chronic hepatitis C, by state or jurisdiction — United States, 2022
- Table 3.6. Number and rate of newly reported cases of chronic hepatitis C, by demographic characteristics — United States, 2022
- Table 3.7. Numbers and rates of deaths with hepatitis C listed as a cause of death among residents, by state or jurisdiction — United States, 2018–2022
- Table 3.8. Numbers and rates of deaths with hepatitis C listed as a cause of death among residents, by demographic characteristics — United States, 2018–2022